Dr Peter Robert Letourneau, MD | |
401 Phalen Blvd, Saint Paul, MN 55130-5302 | |
(651) 254-8290 | |
(651) 254-8299 |
Full Name | Dr Peter Robert Letourneau |
---|---|
Gender | Male |
Speciality | Plastic And Reconstructive Surgery |
Experience | 22 Years |
Location | 401 Phalen Blvd, Saint Paul, Minnesota |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1699899609 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208200000X | Plastic Surgery | 61308 (Minnesota) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Regions Hospital | Saint paul, MN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Healthpartners Medical Group | 1759293954 | 1430 |
News Archive
RCSI and Bayer have today announced a research collaboration that aims to improve treatments for people with severe haemophilia.
Sosei Group Corporation ("Sosei"; TSE Mothers Index: 4565) announce that Novartis have presented the results of their two Phase II studies evaluating the efficacy, safety and tolerability of QVA149 at the annual congress of the European Respiratory Society (ERS) in Vienna.
Literally hundreds of clinical trials, including some that have gained widespread attention, have been done on the possible benefits of omega-3 fatty acids for the prevention of heart disease - producing conflicting results, varied claims, and frustrated consumers unsure what to believe.
A special focus on rogue proteins may hold future promise in stopping the progression of nerve cell destruction in people who have amyotrophic lateral sclerosis or frontotemporal dementia.
Roche, makers of ACCU-CHEK® blood glucose meters, infusion pumps, lancing devices and data management systems for people with diabetes, received the Juvenile Diabetes Research Foundation International's "Chancellor's Award" during the JDRF Annual Conference in Washington, D.C. The "Chancellor's Award" recognizes and honors longstanding JDRF corporate partners.
› Verified 7 days ago
Entity Name | Group Health Plan Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1710924683 PECOS PAC ID: 1759293954 Enrollment ID: O20031105000417 |
News Archive
RCSI and Bayer have today announced a research collaboration that aims to improve treatments for people with severe haemophilia.
Sosei Group Corporation ("Sosei"; TSE Mothers Index: 4565) announce that Novartis have presented the results of their two Phase II studies evaluating the efficacy, safety and tolerability of QVA149 at the annual congress of the European Respiratory Society (ERS) in Vienna.
Literally hundreds of clinical trials, including some that have gained widespread attention, have been done on the possible benefits of omega-3 fatty acids for the prevention of heart disease - producing conflicting results, varied claims, and frustrated consumers unsure what to believe.
A special focus on rogue proteins may hold future promise in stopping the progression of nerve cell destruction in people who have amyotrophic lateral sclerosis or frontotemporal dementia.
Roche, makers of ACCU-CHEK® blood glucose meters, infusion pumps, lancing devices and data management systems for people with diabetes, received the Juvenile Diabetes Research Foundation International's "Chancellor's Award" during the JDRF Annual Conference in Washington, D.C. The "Chancellor's Award" recognizes and honors longstanding JDRF corporate partners.
› Verified 7 days ago
Entity Name | Hennepin Healthcare System Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1033138136 PECOS PAC ID: 4789684861 Enrollment ID: O20070207000467 |
News Archive
RCSI and Bayer have today announced a research collaboration that aims to improve treatments for people with severe haemophilia.
Sosei Group Corporation ("Sosei"; TSE Mothers Index: 4565) announce that Novartis have presented the results of their two Phase II studies evaluating the efficacy, safety and tolerability of QVA149 at the annual congress of the European Respiratory Society (ERS) in Vienna.
Literally hundreds of clinical trials, including some that have gained widespread attention, have been done on the possible benefits of omega-3 fatty acids for the prevention of heart disease - producing conflicting results, varied claims, and frustrated consumers unsure what to believe.
A special focus on rogue proteins may hold future promise in stopping the progression of nerve cell destruction in people who have amyotrophic lateral sclerosis or frontotemporal dementia.
Roche, makers of ACCU-CHEK® blood glucose meters, infusion pumps, lancing devices and data management systems for people with diabetes, received the Juvenile Diabetes Research Foundation International's "Chancellor's Award" during the JDRF Annual Conference in Washington, D.C. The "Chancellor's Award" recognizes and honors longstanding JDRF corporate partners.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Peter Robert Letourneau, MD 8170 33rd Ave S, Ms: 21110q, Bloomington, MN 55425-4516 Ph: () - | Dr Peter Robert Letourneau, MD 401 Phalen Blvd, Saint Paul, MN 55130-5302 Ph: (651) 254-8290 |
News Archive
RCSI and Bayer have today announced a research collaboration that aims to improve treatments for people with severe haemophilia.
Sosei Group Corporation ("Sosei"; TSE Mothers Index: 4565) announce that Novartis have presented the results of their two Phase II studies evaluating the efficacy, safety and tolerability of QVA149 at the annual congress of the European Respiratory Society (ERS) in Vienna.
Literally hundreds of clinical trials, including some that have gained widespread attention, have been done on the possible benefits of omega-3 fatty acids for the prevention of heart disease - producing conflicting results, varied claims, and frustrated consumers unsure what to believe.
A special focus on rogue proteins may hold future promise in stopping the progression of nerve cell destruction in people who have amyotrophic lateral sclerosis or frontotemporal dementia.
Roche, makers of ACCU-CHEK® blood glucose meters, infusion pumps, lancing devices and data management systems for people with diabetes, received the Juvenile Diabetes Research Foundation International's "Chancellor's Award" during the JDRF Annual Conference in Washington, D.C. The "Chancellor's Award" recognizes and honors longstanding JDRF corporate partners.
› Verified 7 days ago
Jennifer Ann Cameron, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 310 Smith Ave N Ste 330, Saint Paul, MN 55102 Phone: 651-241-6800 Fax: 651-241-6850 | |
Craig H Johnson, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 280 Smith Ave N Ste 700, Saint Paul, MN 55102 Phone: 651-241-3535 | |
Dr. Joseph I Skow, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 393 Dunlap St N, 832, Saint Paul, MN 55104 Phone: 651-646-2717 Fax: 651-646-5144 | |
Dr. Courtney Anne Carpenter, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 200 University Ave E, Saint Paul, MN 55101 Phone: 651-602-3277 | |
Warren Schubert, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 401 Phalen Blvd, Saint Paul, MN 55130 Phone: 651-254-8290 Fax: 651-254-8299 | |
Christopher James Hillard, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 401 Phalen Blvd, Saint Paul, MN 55130 Phone: 651-254-8290 |